Xiangxue Pharmaceutical (300147): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 6,43 Renminbi Yuan | 11,84 Renminbi Yuan | 5,9 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 661.279.045 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 1.595.407,306 | 1.858.662,132 | 2.299.287,681 | 2.187.069,9 | 2.970.575,841 | 3.072.090,655 | 2.786.199,516 | 2.504.252,347 | 2.187.317,438 | 1.862.087,873 | 1.464.604,841 | 1.523.980,137 | 1.261.114,651 | 801.020,212 | 616.090,22 | 513.383,583 | 378.633,317 | 294.808,98 | 258.307,517 |
Cashflow aus operativer Geschäftstätigkeit | 139.633,034 | 18.174,822 | 263.441,902 | 227.377,262 | 257.562,269 | 257.180,838 | 83.019,533 | 91.238,235 | 109.533,184 | 198.481,275 | 159.890,412 | 165.580,27 | 328.367,622 | 118.907,426 | 29.553,113 | 45.465,558 | 46.186,863 | 55.723,417 | 138.016,021 |
▸ Operative Cashflow Marge | 8,75% | 0,98% | 11,46% | 10,4% | 8,67% | 8,37% | 2,98% | 3,64% | 5,01% | 10,66% | 10,92% | 10,86% | 26,04% | 14,84% | 4,8% | 8,86% | 12,2% | 18,9% | 53,43% |
Investitionsausgaben (CapEx) | 21.514,128 | 35.241,775 | 56.033,759 | 367.269,064 | 562.739,175 | 707.419,913 | 661.093,522 | 495.464,449 | 777.865,205 | 1.966.047,349 | 276.952,397 | 243.854,229 | 318.549,116 | 418.122,945 | 230.686,262 | 56.866,906 | 52.856,844 | 137.712,9 | 144.730,555 |
Cashflow aus Investitionstätigkeit | - | 34.961,7 | -53.657,325 | 379.262,499 | -112.804,977 | -1.238.545,125 | 848.175,154 | 219.635,918 | -873.282,044 | -2.569.662,567 | -612.698,516 | -503.763,31 | -578.311,197 | -451.510,176 | -368.082,362 | -56.866,906 | -52.856,844 | -82.892,028 | -93.036,955 |
Cashflow aus Finanzierungstätigkeit | - | -67.947,239 | -200.629,18 | -652.773,16 | -450.220,76 | 1.124.886,313 | -1.031.450,06 | -757.482,148 | 1.163.414,868 | 2.221.094,469 | 788.267,681 | -111.166,741 | -290.236,272 | 837.006,317 | -24.734,811 | 1.067.162,632 | 64.757,886 | 12.509,951 | -10.358,416 |
Freier Cashflow | 118.118,905 | -17.066,953 | 207.408,143 | -139.891,802 | -305.176,906 | -450.239,075 | -578.073,989 | -404.226,214 | -668.332,021 | -1.767.566,074 | -117.061,985 | -78.273,959 | 9.818,506 | -299.215,519 | -201.133,149 | -11.401,348 | -6.669,981 | -81.989,483 | -6.714,534 |
▸ Freie Cashflow Marge | 7,4% | -0,92% | 9,02% | -6,4% | -10,27% | -14,66% | -20,75% | -16,14% | -30,55% | -94,92% | -7,99% | -5,14% | 0,78% | -37,35% | -32,65% | -2,22% | -1,76% | -27,81% | -2,6% |
Ausgeschüttete Dividenden | -5.839,272 | -50.549,008 | -140.650,45 | -175.804,424 | -216.910,165 | -31.338,858 | -21.281,161 | -207.380,945 | -172.230,165 | -157.262,47 | -135.197,179 | -150.272,851 | -147.704,834 | -79.984,834 | -54.734,811 | -64.702,128 | -11.844,453 | -42.006,064 | -17.631,623 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | -269,744 | -376,182 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.